Neil Kumar is the founder of BridgeBio Oncology Therapeutics. BridgeBio Oncology Therapeutics has raised $200M in total funding. Latest round: Growth.
Neil Kumar is the Founder and Chief Executive Officer of BridgeBio Pharma, Inc., a company focused on creating medicines for genetic diseases. He also serves as the Executive Chairman of BridgeBio Oncology Therapeutics (BBOT), a subsidiary launched with $200M in private external capital. Before founding BridgeBio in 2015, Neil was a Principal at Third Rock Ventures and an Associate Principal at McKinsey & Company.
Full founder directory · Investor directory · Company funding database · Fundraising library